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Background. The study’s aim was to determine whether conventional hemostasis (CH) or the Harmonic Scalpel (HS) results in
shorter operative times for thyroidectomy and to evaluate the incidence of postoperative complications with each approach.
Methods. A literature search was conducted from study inception to September 30, 2008. Included studies randomized
thyroidectomy patients to either CH or HS and reported the incidence of postoperative transient recurrent laryngeal nerve
dysfunction (RLND) and hypocalcemia. Results. Nine RCTs were included. Use of the HS reduced operative time by 23.1 minutes
(95% CI=13.8, 32.33). There was no diﬀerence in the incidence of transient RLND (RR=1.25, 95% CI=.56, 2.76), but a lower
rate of transient hypocalcemia with the use of the HS (RR=.69, 95% CI=.51, .92). Conclusions. The use of HS in thyroidectomy
signiﬁcantly reduces operative time and is associated with a reduction in postoperative hypocalcemia compared to CH.
1.Introduction
There have been few developments in the technical aspects
of thyroid surgery since the surgical approach described by
Kocher greater than a century ago [1]. Given the signiﬁcant
vascularity of the thyroid gland [2] and the relatively small
operative ﬁeld, meticulous hemostasis has and will always be
animportantprerequisiteforasuccessfuloutcomeinthyroid
surgery. The mainstay for achieving hemostasis in thyroid
surgery has been tying and/or clipping of blood vessels,
botheﬀectivebuttime-consumingtechniques.Inthecurrent
climate of healthcare constraints and long surgical waiting
lists, any methodology that can reduce operative times
while maintaining acceptable complication rates warrants
investigation.
The Harmonic Scalpel (Ethicon Endosurgery, Cincin-
nati, Ohio) was introduced into the surgeon’s armamentar-
ium almost two decades ago. Using mechanical vibrations
at 55.5kHz, this device is able to cut and coagulate tissue
simultaneously.Theproposedadvantagesofusingthisdevice
over traditional electrocautery include less lateral thermal
tissue injury, a lack of neuromuscular stimulation, and
the avoidance of electrical energy transmission either to
or through the patient [3]. Since the adoption of the
Harmonic Scalpel (HS) into modern surgical practice, its
utility for a wide variety of operations has been well
documented. Forexample, arandomized prospectiveclinical
trial demonstrated its ability to diminish blood loss as well as
operative time for laparoscopic Nissen fundoplication [4].
Over the last decade, many reports have evaluated the
utility of the HS for thyroid surgery and the majority of
these studies have been carried out at European centers. The
investigators have shown similar results regarding reduced
operative times with its utilization, but conﬂicting results
regarding other postoperative outcomes such as transient
postoperative hypocalcemia and recurrent laryngeal nerve
dysfunction (RLND). These complications are relatively
uncommon and the number of cases reported in individual
studies is limited. Consolidating the data may allow for
elucidation of signiﬁcant associations between HS utilization
and postoperative complications. To date, no meta-analysis
evaluating the utilization of HS in thyroid surgery has2 International Journal of Surgical Oncology
been reported. The purpose of this study was to determine
whether conventional hemostasis (CH) or the HS results in
shorter operative times for thyroidectomy and to evaluate
the incidence of postoperative complications with each
approach.
2. Methods
2.1. Identiﬁcation of Trials. We sought to identify prospec-
tive,randomizedclinicaltrialscomparingHStoCHmethods
(i.e., ties, clips, and/or electrocautery) for thyroidectomy
utilizing a computerized literature search. We searched the
Cochrane Central Register of Controlled Trials, MEDLINE
andEMBASE(January1,1995toSeptember30,2008),using
the following index terms: thyroidectomy, thyroid surgery,
harmonic scalpel, harmonic shears, ultrasonic shears, ultra-
sonic scalpel, ultrasonic coagulator, ultrasonic dissector,
ultrasonic dissection, ultrasonically activated scalpel, ultra-
sonic scissors, and coagulating shears. In addition, we
reviewed the reference lists of retrieved articles, contacted
experts in the ﬁeld, and contacted the major manufacturer
of the HS (Ethicon Endosurgery) to determine if they
were funding or aware of any trials being conducted using
their product. We also searched the proceedings of major
endocrine surgery conferences for any reported trials that
may not have been published. All studies were considered
relevant irrespective of publication status or the language of
publication.
2.2. Study Eligibility. We restricted our study to adults older
than18yearsofage.Onlystudiescomparingtraditionalopen
thyroidectomy utilizing CH techniques to thyroidectomy
using the HS were considered. Any studies evaluating video-
assisted or endoscopic thyroidectomy were excluded. Studies
where additional procedures were carried out at the time
of thyroidectomy (e.g., lateral neck lymph node dissection)
were also excluded, unless these additional procedures
were accounted for by subtracting the time for the added
p r o c e d u r ef r o mt h eo v e r a l lo p e r a t i v et i m e .T h y r o i ds u r g e r y
for either benign or malignant histology was included.
The principal outcome evaluated was the mean operative
time, measured in minutes, for total or subtotal thyroidec-
tomies carried out utilizing the two surgical techniques.
Although studies could include a combination of total and
subtotal thyroidectomies and thyroid lobectomies, they were
excluded if they did not report a mean operative time
speciﬁcally for the total and subtotal thyroidectomies. The
secondary outcomes we evaluated were the incidence of
transient postoperative RLND and hypocalcemia. Transient
RLND was not well deﬁned in most studies. One study
deﬁned RLND as transient if vocal cord function recovered
within twelve months of the operation [5]. Some studies
did not provide an explanation for how transient RLND
was diagnosed [6–8]. In the majority of the papers, post-
operative laryngoscopy was performed on every patient to
assess vocal cord function [5, 9–13]. Transient postoperative
hypocalcemia was deﬁned either by biochemical parame-
ters or by clinical symptoms or both. Some studies did
not describe how postoperative hypocalcemia was deﬁned.
Although studies could report on a variety of secondary
postoperative outcomes (e.g., amount and/or duration of
wound drainage, postoperative hematoma formation, pain,
analgesic requirements, time to hospital discharge, cost-
eﬀectiveness), they were excluded if they did not report these
two speciﬁc outcomes.
To be included, studies had to be prospective, ran-
domized clinical trials and observational studies were not
included in the analysis. Clearly blinding is not feasible in
studies evaluating two diﬀerent surgical techniques, though
it was noted if assessors of the postoperative outcomes were
blinded to the intervention.
Regarding data collection and analysis, the two authors
(AM and SMW) independently assessed the titles and
abstracts of studies retrieved from the literature search
and obtained full articles for all those that appeared to
satisfy inclusion criteria, ultimately including those that
met inclusion criteria after in depth review. The data
from those studies were extracted independently by the
authors, and any diﬀerences were resolved by discussion.
The following information was abstracted for each study:
year of publication, language of publication, country of
origin, study design (including details on randomization,
blinding, allocationconcealment,intention-to-treat analysis,
and losses to follow-up), provision of industrial support for
the study, reason for ineligibility if the study was ultimately
excluded, number of patients enrolled in each study arm,
indication for thyroidectomy, type of thyroidectomy car-
ried out (e.g., partial versus total versus subtotal), details
regarding type of HS and CH utilized (ties versus clips
versus electrocautery), mean operative time for total and
subtotal thyroidectomies in each group, number of cases
of transient and permanent postoperative hypocalcemia
(either symptomatic or biochemical), number of cases of
postoperative transient or permanent RLND, and number of
cases of postoperative hematoma formation. Study validity is
presented qualitatively though no formal validity score was
assigned.
2.3. Statistical Analysis. For the primary outcome, the meta-
analysis evaluated the weighted mean diﬀerence in operative
times between thyroidectomy groups (HS versus CH) and
thestandarddeviationofthediﬀerencefromindividualstud-
ies using the METAN command in STATA 9.2 (StataCorp,
College Station, Texas). In one study, the data regarding
operative times was not reported as a mean with standard
deviation, but after correspondence with the authors, the
data was provided in such a format as to allow inclusion
in the analysis [11]. In 2 cases, attempts to contact the
authors were unsuccessful and thus these papers could not
be included in the analysis, though they had otherwise met
inclusion criteria [14, 15]. Signiﬁcant heterogeneity across
studies was noted; thus a pooled estimate of the diﬀerence in
operative time was generated using a random eﬀects model
[16]. A sensitivity analysis excluding the two studies that
disclosed ﬁnancial support from the HS manufacturers was
also carried out.International Journal of Surgical Oncology 3
34 potentially relevant studies
screened for retrieval
19 excluded 15 retrieved for more
detailed evaluation
1e v a l u a t e d
additional
procedures
18 retrospective
or non-
randomized
6 excluded 9 included
3 duplicate reports
on same patient cohort
3 relevant data
not provided
Figure 1: Flow diagram showing the number of studies initially identiﬁed and the reasons for study exclusion.
For the secondary outcomes of postoperative RLND and
hypocalcemia, results are presented as risk ratios (RRs).
The ﬁxed eﬀects model was utilized to obtain the summary
estimates of the logRR from the group of studies. We did
not proceed to a random eﬀects model once the ﬁxed
eﬀects analysis did not reveal any signiﬁcant heterogeneity
(Q statistic).
Publication bias was assessed with Begg’s and Egger tests
and Begg’s funnel plot [17, 18]. A P-value of <.05 was
considered statistically signiﬁcant.
3. Results
Thirty-four studies that potentially met inclusion criteria
were identiﬁed from the literature search. After abstract
screening, 19 were excluded for variety of reasons. Of the
15 that were reviewed in depth, 6 were excluded, leaving
9 studies that were incorporated into the meta-analysis.
Figure 1 depicts a ﬂow diagram of the study selection process
and Table 1 summarizes the characteristics of the studies
included in the meta-analysis. There were no incidents of
author disagreement in either the study selection or data
extraction phase
Regarding the primary outcome of mean operative time,
thepooledestimateoftheweightedmeandiﬀerence(WMD)
in operative time obtained from a random eﬀects model was
23.1 minutes (95% CI = 13.8, 32.33). This was statistically
signiﬁcant, with a P-value of <.001 (Figure 2). The χ2 test
for heterogeneity was signiﬁcant with a P-value of <.001.
Tests for publication bias were not statistically signiﬁcant
(P = .97). See Figure 3 for Begg’s funnel plot.
Regarding secondary outcomes, the pooled estimate and
95% conﬁdence interval of the relative risk of postoperative
transient RLND from a ﬁxed eﬀects model was 1.25 (P =
.59; 95% CI = 0.56, 2.76). Thus, there is a trend toward an
increased risk of transient RLND with the use of HS, but the
overall number of cases of this was small and this was not
a statistically signiﬁcant ﬁnding (see Figure 4). Two studies
reported no cases of transient RLND [10. 12] and were
excluded from this analysis. The χ2 test for heterogeneity was
not signiﬁcant (P-value = .51); thus we did not proceed to a
random eﬀects analysis.
The pooled estimate and 95% conﬁdence interval of the
relative risk of postoperative transient hypocalcemia from a
ﬁxed eﬀects model was 0.69 (P = .01; 95% CI = 0.51, 0.92).
Thus, there was a statistically signiﬁcant reduced risk of
transient postoperative hypocalcemia with the use of HS (see
Figure 5). The χ2 test for heterogeneity was not signiﬁcant
(P-value = .53); so a random eﬀects analysis was not carried
out.
A sensitivity analysis excluding studies with industry
s u p p o r tr e v e a l e da ne v e ng r e a t e rr e d u c t i o ni no p e r a t i v et i m e
with use of the HS (25 minutes; 95% CI = 16.3, 33.62).
Interestingly, there were a total of 3 cases of postoperative
hematoma in the CH group and 1 in the HS group
(Table 1) suggesting a trend toward a lower incidence of this
serious postoperative complication with the HS. However,
the overall numbers are too small to draw any meaningful
conclusions.
The quality of the studies was assessed based on the
following criteria: appropriateness of randomization, alloca-
tion concealment, blinding of patients, blinding of outcome
assessors, utilization of intention-to-treat analysis, and a
description of any patients that were lost to follow-up. In
most cases, these parameters were not speciﬁed and thus the
methodological quality of the included studies could only be
deemed as fair. These results are presented in Table 2.
4. Discussion
Utilization of the HS for total and subtotal thyroidec-
tomy signiﬁcantly reduced operative time compared to CH4 International Journal of Surgical Oncology
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 34.1 (31.25,36.95)  Hallgrimsson  12.5
 22.1 (15.96,28.24)  Lombardi  12
 27.1 (21.60,32.60)  Yildirim  12.2
 10.7 (6.20,15.20)  Kilic  12.3
 6.7 (3.16,10.24)  Miccoli  12.5
 40 (33.74,46.26)  Frazzetta  12
 32 (2.00,62.00)  Cordon   5.4
 15 (8.35,21.65)  Ortega 1 1 . 9
 25.8 (9.54,42.06)  Defechereux   9.1
 23.07 (13.8,32.33)  Overall (95% CI)
Conventional
hemostasis
Harmonic
scalpel WMD (95% CI) Weight (%)
−62 0 23.1 62
WMD (mins)
Figure 2: Forest plot depicting individual and pooled weighted mean diﬀerence (WMD) in operative times with 95% conﬁdence intervals.
Table 2: Study validity.
Author Randomization Concealed Patients Outcome assessors Intention- to-treat Patients LTFU?
Done Adequate allocation blinded blinded Analysis
Hallgrimsson Yes UC UC UC UC Yes UC
Lombardi Yes UC UC Yes UC UC UC
Yildirim Yes UC UC UC UC UC UC
Kilic Yes UC UC UC UC UC UC
Miccoli Yes UC UC Yes UC UC UC
Frazzetta Yes UC UC UC UC UC UC
Cordon Yes Yes UC UC Yes UC UC
Ortega Yes UC UC UC UC UC UC
Defechereux Yes Yes UC UC UC UC UC
UC: unclear; LTFU: loss to follow-up.
−20
0
20
40
60
0 5 10 15
Standard error of WMD
Figure 3: Begg’s funnel plot with pseudo 95% conﬁdence limits.
techniques by greater than 23 minutes (P-value <. 001).
Furthermore, there was a 31% decreased risk of transient
postoperative hypocalcemia with HS utilization compared
to CH techniques (pooled RR = 0.69, P-value = .01) and
there was also no statistically signiﬁcant diﬀerence in the risk
of transient postoperative RLND between the two groups
(pooled RR = 1.25, P-value = .59). We conclude that not
only is HS utilization for total thyroidectomy signiﬁcantly
faster than the conventional approach, with acceptable
postoperative complication rates, but also it may even
protect against the development of transient postoperative
hypocalcemia.
All of the studies uniformly report decreased operating
time with the use of an HS. This is not a surprising observa-
tion, given that the same outcome has been reported repeat-
e d l yf o rav a r i e t yo fo t h e rs u r g i c a lp r o c e d u r e s[ 19–21]. With
theexceptionofasingleMexicanstudy,allofthereportswere
from European centers. There is no reason to believe that the
patientsrequiringthyroidsurgeryareanydiﬀerentinEurope
than in North America and thus we believe that our results
are generalizable to other patient populations. From the
literaturesearch,tworeportsfromU.S.centersevaluatingHS
use for thyroidectomy were identiﬁed but excluded because
of their retrospective study design. Both of these studies also
found the HS to be safe and time-saving [22, 23].6 International Journal of Surgical Oncology
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 1.25 (0.56,2.76)  Overall (95% CI)
Conventional
hemostasis
Harmonic
scalpel RR (95% CI) Weight (%)
−1 11.25 10
RR
Figure 4: Forest plot depicting individual and pooled risk ratios (RRs) with 95% conﬁdence intervals (CIs) for transient postoperative
recurrent laryngeal nerve dysfunction.
 0.63 (0.23,1.74)  Hallgrimsson   8.5
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 0.83 (0.27,2.58)  Ortega   6.9
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Figure 5: Forest plot depicting individual and pooled risk ratios (RRs) with 95% conﬁdence intervals (CIs) for transient postoperative
hypocalcemia.
All studies reported an increased risk of postopera-
tive hypocalcemia with conventional hemostasis techniques,
though only one report had a large enough cohort for the
association to be statistically signiﬁcant [12]. Though the
mechanism is not fully understood, transient hypocalcemia
observed after total thyroidectomy is believed to be related
to traumatization of the parathyroid glands, which are
anatomically intimately related to the thyroid gland and
share its blood supply. We speculate that use of the HS
may facilitate dissection of the parathyroid glands in a
plane farther away from the parathyroid gland capsule,
thus reducing the chance of damaging their blood supply,
directly or indirectly, with either mechanical forces or
electrical currents. Thus, this ﬁnding of reduced transient
postoperative hypocalcemia with HS utilization does seem
biologically plausible and highlights an important rationale
for conducting the meta-analysis. When an outcome is
relatively uncommon, individual studies may all trend
toward that same outcome though none may have the
power to support statistical signiﬁcance, but calculating
a pooled estimate may allow for the determination of a
statistically signiﬁcant association. It is diﬃcult to draw
any conclusions regarding permanent hypoparathyroidism
and HS utilization. Permanent hypoparathyroidism is a rareInternational Journal of Surgical Oncology 7
complication of thyroidectomy, and there were only three
reported cases of this among the nine studies, two of which
occurredintheCHgroupandoneintheHSgroup(Table 1).
The complication of RLND after thyroidectomy is also
an extremely uncommon occurrence. Included studies had
conﬂicting results in terms of the risks of RLND with HS
utilization compared to CH, and all reported either very
few or no cases of this complication. In the current meta-
analysis, there were only twenty-two incidents of transient
RLND out of 822 total thyroidectomies (.03%) or 1,644
nerves at risk (.01%). Given that HS has been shown
to cause less collateral thermal injury than conventional
electrocautery, we would expect to see less RLND in the HS
group. Unfortunately, the numbers in this analysis are too
small to generate any meaningful conclusions. Only one case
of permanent RLND occurred in a patient who underwent
the CH technique. The time cutoﬀ to diﬀerentiate between
transient and permanent RLND was not well deﬁned in
the studies, but most investigators did use postoperative
laryngoscopyinallpatientstodocumentvocalcordparalysis.
Regarding the internal validity of included studies, one
must accept that for studies evaluating surgical techniques,
blinding of the surgeon is not possible. However, patients
can be blinded to the procedure they have undergone
to minimize reporting bias when evaluating postoperative
outcomes such as symptomatic hypocalcemia or pain. Fur-
thermore, those individuals evaluating outcomes (operative
time, RLND, hypocalcemia) can also be blinded to the
intervention to reduce observation bias, and this was only
explicitly carried out in a single study [9]. Ideally, authors
shouldalsogiveadetaileddescriptionoftheirrandomization
procedures, allocation concealment, and use of intention-
to-treat analysis, which was not consistently reported in the
studies included in this meta-analysis. To assure internal
validity, future randomized studies evaluating this question
should include details addressing these issues. The quality of
a meta-analysis is only as good as the reports from which
it is derived, and so our study is inherently limited by the
methodological limitations of the included reports.
No tests of publication bias were statistically signiﬁcant.
Begg’s funnel plot for the pooled estimate of the WMD in
operative time did exhibit some asymmetry, but this was not
statistically signiﬁcant. The asymmetry was likely a result
of between-study heterogeneity (tau-squared = 175.88).
When between-study heterogeneity is large and when the
number of included studies is small, none of these tests
to detect publication bias work well. Though all studies
found that thyroidectomy was faster with the HS, they were
quite heterogeneous in terms of the baseline length of time
required to carry out a conventional thyroidectomy (range
from 46.7 to 168.8 minutes). This observed diﬀerence in
time required to carry out the same operation is quite
striking. The heterogeneity may have been due to the size
of the gland that was being resected, which was not clearly
deﬁned in all studies. In addition, all of the thyoidectomies
in the Hallgrimsson study, which reported the longest mean
operative time for conventional thyroidectomy, were carried
out for Graves’ thyrotoxicosis, wherein the vascularization
of the thyroid gland can be very extensive. In contrast, the
majority of thyroidectomies in the study reporting the fastest
mean operative time excluded patients with Graves’ disease
or extensive goiters [12].
One must consider whether or not benign versus
malignant thyroid pathology aﬀected our results. All of the
studies incorporated in the meta-analysis excluded patients
requiringeitheracentralorlateralcompartmentlymphnode
dissection; thus this could not have played a role in operative
time or incidence of postoperative hypocalcemia. Of the 9
studies, 4 excluded malignant disease (7, 10, 11, 13), 3 had
nosigniﬁcantdiﬀerenceintheproportionofmalignantcases
betweentheHSandCHgroups(5,6,9),1onlyincludedlow-
risk T1N0M0 papillary thyroid cancers (12), and 1 did not
clearly outline the pathologies. Given this, we do not feel that
thyroid pathology is confounding our results for the primary
or secondary outcomes.
Another consideration when interpreting the results of
the current meta-analysis is that surgeons who conduct these
trials may have signiﬁcantly more experience with the HS
than the average thyroid surgeon, and the timesaving eﬀect
of the HS might be exaggerated compared to what a less-
familiarsurgeonwouldexperiencewhenﬁrstadoptingitsuse
into their practice.
Future prospective, randomized trials of larger patient
cohorts with more detailed and uniform deﬁnitions of
postoperative complications, randomization procedures,
intention-to-treat analyses, and blinding of outcome asses-
sors are needed to draw more meaningful conclusions with
regard to the inﬂuence of HS utilization on complications
after total or subtotal thyroidectomy. In addition, cost-
eﬀectiveness analyses to determine whether the costs saved
from the reduced time spent in the operating theater
outweigh the added cost of the HS scalpel would also be
important. Several of the studies did report reduced overall
cost associated with the HS [7, 8, 10] while another reported
no diﬀerence in overall costs when comparing the two
techniques [5]. Other beneﬁts seen with HS demonstrated in
thesestudiesincludedlessoperativebleeding[6,8–12],fewer
cases of postoperative hematoma formation [7], fewer ties
used[6,8,9,13],lessdrainutilization[13],lesspostoperative
painoranalgesicrequirements[10,12],andsmallerincisions
[6]. The impact of a recently introduced, smaller handheld
HS on thyroid surgery outcomes also warrants further study.
Reports of the use of another vessel sealing technology, the
Ligasure (Covidien, Boulder, Colorado), for thyroid surgery
have emerged in the recent literature, and comparisons
between this device and the HS would also be of interest.
From the current study, we are able to deﬁnitively conclude
that not only does the use of the HS signiﬁcantly decrease
operative time compared to CH techniques with ties, clips,
and/or electrocautery but it is also safer in terms of reducing
the incidence of transient postoperative hypocalcemia.
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